Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030220 · ClinicalTrials.gov registry record
Testosterone Levels and Cutibacterium
A clinical trial of Arthroplasty, Replacement, Shoulder, sponsored by University of Washington.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05030220: Recruiting study of Arthroplasty, Replacement, Shoulder, sponsored by University of Washington.
NCT05030220 is a study of Arthroplasty, Replacement, Shoulder that is actively recruiting participants, run by University of Washington. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05030220, a study of Arthroplasty, Replacement, Shoulder, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Phase 1: In 51 patients undergoing shoulder arthroplasties, total serum testosterone, free testosterone and sex hormone binding globulin levels obtained in the clinic before surgery were correlated with the levels of Cutibacterium on the skin in clinic, in the operating room prior to surgery, and in the skin incision. Phase 2: The investigators wish to determine if preoperative serum testosterone levels are associated with risk for shoulder PJI (periprosthetic joint infection) in patients undergoing primary shoulder arthroplasty. Also to determine if preoperative serum testosterone levels are predictive of bacterial load of deep tissue cultures taken at the time of revision shoulder arthroplasty in patients undergoing primary shoulder arthroplasty.
Conditions Studied
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2027-01-01 |
What NCT05030220 shows while recruiting
NCT05030220 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Arthroplasty, Replacement, Shoulder appearing as the primary indexed condition, and to 0 interventions.
NCT05030220 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05030220 about?
NCT05030220 is a clinical study titled "Testosterone Levels and Cutibacterium". Phase 1: In 51 patients undergoing shoulder arthroplasties, total serum testosterone, free testosterone and sex hormone binding globulin levels obtained in the clinic before surgery were correlated with the levels of Cutibacterium on the skin in clinic, in the operating room prior to surgery, and in...
What is the current status of trial NCT05030220?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-07-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05030220 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Shoulder.
Who is sponsoring clinical trial NCT05030220?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05030220 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI